Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanna Liuzzo

Showing results (31-40 of 272) with videos related to

Pageof 28
Sort By:
European Heart Journal|February 8, 2021
When less is more: dual antiplatelet therapy in elective percutaneous coronary interventionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|December 19, 2025
Weekly Journal Scan: GRACE 3.0 redefines cardiovascular risk assessment and individualized care in non-ST-elevation acute coronary syndromes through machine learningGiovanna Liuzzo, Massimo Volpe
European Heart Journal|June 7, 2021
Modulating the gut microbiome with dietary interventions to reduce cardiometabolic disease riskGiovanna Liuzzo, Leonarda Galiuto
European Heart Journal|October 25, 2023
Moving a STEP forward in the treatment of patients with obesity and heart failure with preserved ejection fractionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 23, 2022
A SECURE polypill as a strategy at the heart of secondary preventionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|February 21, 2022
Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debateGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 15, 2022
Volume of physical activity and cardiovascular health status: is more necessarily better?Leonarda Galiuto, Giovanna Liuzzo
European Heart Journal|February 15, 2022
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fractionGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 8, 2022
Therapeutic-dose heparin should integrate the standard of care of moderately ill patients with COVID-19 admitted to hospitalGiovanna Liuzzo, Carlo Patrono
European Heart Journal|January 26, 2022
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?Massimo Volpe, Giovanna Liuzzo
Pageof 28

Showing results (31-40 of 272) with videos related to

Sort By:
Pageof 28
European Heart Journal|February 8, 2021
When less is more: dual antiplatelet therapy in elective percutaneous coronary interventionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|December 19, 2025
Weekly Journal Scan: GRACE 3.0 redefines cardiovascular risk assessment and individualized care in non-ST-elevation acute coronary syndromes through machine learningGiovanna Liuzzo, Massimo Volpe
European Heart Journal|June 7, 2021
Modulating the gut microbiome with dietary interventions to reduce cardiometabolic disease riskGiovanna Liuzzo, Leonarda Galiuto
European Heart Journal|October 25, 2023
Moving a STEP forward in the treatment of patients with obesity and heart failure with preserved ejection fractionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|September 23, 2022
A SECURE polypill as a strategy at the heart of secondary preventionGiovanna Liuzzo, Carlo Patrono
European Heart Journal|February 21, 2022
Percutaneous coronary intervention vs. coronary artery bypass graft for left main coronary artery disease: a never-ending debateGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 15, 2022
Volume of physical activity and cardiovascular health status: is more necessarily better?Leonarda Galiuto, Giovanna Liuzzo
European Heart Journal|February 15, 2022
PARADISE-MI suggests a limited role of intensified neuro-hormonal inhibition in the management of acute myocardial infarction with reduced ejection fractionGiovanna Liuzzo, Massimo Volpe
European Heart Journal|February 8, 2022
Therapeutic-dose heparin should integrate the standard of care of moderately ill patients with COVID-19 admitted to hospitalGiovanna Liuzzo, Carlo Patrono
European Heart Journal|January 26, 2022
VANISHing the progression of cardiac abnormalities in hypertrophic cardiomyopathy with early use of valsartan?Massimo Volpe, Giovanna Liuzzo
Pageof 28